There has been a failure of current weight loss treatments and programs to stop the progression of the obesity epidemic. The pro-inflammatory component of obesity is now known to lead to serious diseases, including: Type 2 diabetes, cardiovascular disease, cancer, Alzheimer’s disease, fatty liver disease and several autoimmune diseases. Thus, there is a need for a safe and effective product that treats both obesity and the pro-inflammatory component that affects development of disease.
Molecular hydrogen (H2) is generated and sustained in H2B*. It is delivered to the stomach by capsule. It promises to create satiety by generating a feeling of fullness for 4-8 hours. It also reduces obesity - associated inflammation by the generation and sustained release of anti-inflammatory H2.
H2B* works by multiple mechanisms:
· Creates an H2 ‘headspace’ in the stomach – giving a feeling of fullness.
· ‘Floats’ a bulk mass in the stomach that adds to satiety.
· Generates and sustains anti-inflammatory H2.
· Contains a prebiotic that generates sustained H2 in the lower G-I Tract.
· H2, itself, has been associated with weight management (1).
(1) Obesity (2011) 19 (7):1396-1403.